We are live on ! Find out more
NEO icon

NeoGenomics

139 hedge funds and large institutions have $743M invested in NeoGenomics in 2017 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 48 increasing their positions, 40 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 12

30% more capital invested

Capital invested by funds: $572M → $743M (+$171M)

20% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 40

3.96% more ownership

Funds ownership: 80.56%84.52% (+4%)

4% more funds holding

Funds holding: 134139 (+5)

11% less funds holding in top 10

Funds holding in top 10: 98 (-1)

Holders
139
Holders Change
+5
Holders Change %
+3.73%
% of All Funds
3.46%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.2%
New
20
Increased
48
Reduced
40
Closed
12
Calls
$1.65M
Puts
Net Calls
+$1.65M
Net Calls Change
+$947K

NEO Hedge Fund Activity: Q3 2017 in Review

139 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q3 2017, worth a combined $743M — up 30% from $572M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new NEO positions and 12 closed out — a net gain of 8 holders — while 48 added to existing stakes and 40 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $11.3M. The largest seller was Next Century Growth Investors, cutting an estimated $5.57M.

  • 139 institutional investors held NeoGenomics (NEO) as of Q3 2017, up from 134 in Q2 2017.
  • Funds reported $743M of NeoGenomics stock for Q3 2017, up 30% quarter-over-quarter.
  • 20 funds opened new NeoGenomics positions in Q3 2017 and 12 closed out, a net change of +8 holders.
  • The largest NeoGenomics buyer in Q3 2017 was Janus Henderson Group, an estimated $11.3M added.
  • The largest NeoGenomics seller in Q3 2017 was Next Century Growth Investors, an estimated $5.57M sold.

Based on aggregated 13F filings for Q3 2017.